Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) Research & Development (2022 - 2023)

Bluejay Diagnostics' Research & Development history spans 2 years, with the latest figure at $1.3 million for Q4 2023.

  • For Q4 2023, Research & Development fell 2.65% year-over-year to $1.3 million; the TTM value through Dec 2023 reached $5.7 million, up 37.63%, while the annual FY2024 figure was $3.5 million, 39.25% down from the prior year.
  • Research & Development for Q4 2023 was $1.3 million at Bluejay Diagnostics, down from $1.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $1.7 million in Q2 2023 and bottomed at $694757.0 in Q1 2022.